EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-0.41%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$266M
AUM Growth
+$266M
(-64%)
Cap. Flow
-$440M
Cap. Flow
% of AUM
-165.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$59.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$499M |
Sector Composition
| 1 | Healthcare | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares MSCI India ETF
INDA
$9.17B
| $125M | 46.91% |
2,425,144
| – | – |
|
|
2
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $121M | 45.4% |
1,991,884
+978,450
| +97% | +$59.4M |
|
3
Foghorn Therapeutics
FHTX
$286M
| $5.74M | 2.16% |
1,573,761
| – | – |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $5.52M | 2.07% |
989,410
| – | – |
|
5
PMV Pharmaceuticals
PMVP
$74.2M
| $2.86M | 1.08% |
2,627,643
| – | – |
|
|
6
SPDR S&P 500 ETF Trust
SPY
$658B
| $2.3M | 0.86% |
4,104
-892,150
| -100% | -$499M |
|
7
Alector
ALEC
$238M
| $1.61M | 0.6% |
1,307,858
| – | – |
|
8
Surrozen
SRZN
$104M
| $1.02M | 0.38% |
87,696
| – | – |
|
9
RAPT Therapeutics
RAPT
$188M
| $803K | 0.3% |
657,899
| – | – |
|
10
Tenaya Therapeutics
TNYA
$184M
| $579K | 0.22% |
1,015,705
| – | – |
|
|
11
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $5.13K | ﹤0.01% |
170,833
| – | – |
|